Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review

• Louis Fox,
• Mieke Van Hemelrijck,
• Charlotte Louise Moss,
• Deborah Enting,
• Beth Russell,
• Nicola Peat,
• Sophia N Karagiannis,
• Miaoqi Chen,
• Gincy George,
• Magdalene Joseph,
• Ridesh Rai

Affiliations

Louis Fox

Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK

Mieke Van Hemelrijck

Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK

Charlotte Louise Moss

Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK

Deborah Enting

Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK

Beth Russell

Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK

Nicola Peat

Guy`s and St Thomas` NHS Foundation Trust, London, UK

Sophia N Karagiannis

St John`s Institute of Dermatology, School of Basic & Medical Biosciences, King`s College London, London, UK

Miaoqi Chen

Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK

Gincy George

Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK

Magdalene Joseph

Immunobiology, School of Immunology & Microbial Sciences, King`s College London, London, UK

Ridesh Rai

Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK